VIKING GLOBAL INVESTORS LP - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 131 filers reported holding GENMAB A/S in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VIKING GLOBAL INVESTORS LP ownership history of GENMAB A/S
ValueSharesWeighting
Q4 2020$15,352,000
+10.8%
377,562
-0.2%
0.04%
-16.0%
Q3 2020$13,853,000
-28.9%
378,404
-34.2%
0.05%
-40.5%
Q2 2020$19,490,000
+9.4%
575,086
-31.6%
0.08%
-9.7%
Q1 2020$17,820,000
+36.3%
840,985
+43.7%
0.09%
+52.5%
Q4 2019$13,070,000
+8.8%
585,309
-1.3%
0.06%
-3.2%
Q3 2019$12,013,000592,9660.06%
Other shareholders
GENMAB A/S shareholders Q4 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 52,148$1,839,2601.67%
Ativo Capital Management LLC 28,442$1,003,1321.13%
HARDING LOEVNER LP 3,204,230$113,013,1830.75%
Hardman Johnston Global Advisors LLC 592,318$20,891,0560.70%
Yorktown Management & Research Co Inc 16,600$585,4820.66%
TORRAY INVESTMENT PARTNERS LLC 104,516$3,686,2790.65%
First Light Asset Management, LLC 157,147$5,542,5750.53%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 44,300$1,561,5750.53%
Capricorn Fund Managers Ltd 37,007$1,305,2370.45%
Legacy Wealth Asset Management, LLC 29,496$1,040,3240.38%
View complete list of GENMAB A/S shareholders